AGFAGDDAPR

SKU: orb3212246

Description

AGFAGDDAPR, a bioactive peptide, is an orally effective, competitive inhibitor of dipeptidyl peptidase-IV (DPP-IV). By inhibiting DPP-IV, AGFAGDDAPR elevates GLP-1 levels, stimulates insulin secretion, improves β-cell function, and suppresses abnormal α-cell proliferation, thus exerting antidiabetic effects. AGFAGDDAPR is suitable for research into type 2 diabetes.

Key Properties

• Target: Glucagon Receptor,Dipeptidyl Peptidase
• CAS Number: 330204-04-1
• MW: 976.00
• Formula: C₄₁H₆₁N₁₃O₁₅
• SMILES: C([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@H](CC1=CC=CC=C1)NC(CNC([C@H](C)N)=O)=O)=O)C)=O)=O)CC(O)=O)=O)CC(O)=O)=O)C)(=O)N2[C@H](C(N[C@@H](CCCNC(=N)N)C(O)=O)=O)CCC2

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

Glucagon Receptor,Dipeptidyl Peptidase